Y-BIOLOGICS
Y-Biologics is specialized in antibody drug since its inception has focused on research and development. They have successfully constructed the unique human antibody library Y-max ABL and new dual antibody platform technology ALiCE. Based on this, they have developed various antibody drugs and become a leading company in the global immuno-chemotherapeutic drug market They are doing their best to leap forward.
Y-BIOLOGICS
Industry:
Biotechnology Health Care
Address:
Seoul, Seoul-t'ukpyolsi, South Korea
Country:
South Korea
Website Url:
http://www.ybiologics.com
Status:
Active
Contact:
+ 82-42-867-9971
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Mobile Non Scaleable Content Euro JQuery CDN Pound Sterling Japanese Yen
Similar Organizations
Reaction Biology
Reaction Biology is an industry leader and innovator specializing in assay services and protein production for early-stage drug discovery
Official Site Inspections
http://www.ybiologics.com Semrush global rank: 270.27 K Semrush visits lastest month: 248.26 K
- Host name: 58.230.162.176
- IP address: 58.230.162.176
- Location: Daegu South Korea
- Latitude: 35.8723
- Longitude: 128.5924
- Timezone: Asia/Seoul
- Postal: 41934
More informations about "Y-Biologics"
Y-BIOLOGICS
Exploring Antibodies, Creating Novel Therapeutics . Y-Biologics is a company specialized in the research and development of novel antibody drugs, striving to become a global leader in the โฆSee details»
Y-BIOLOGICS
Y-Biologics is Koreaโs leading R&D biotech company in the field of antibody drug development. Since establishing Y-Biologics in 2007, our company has focused on the research and development of antibody therapeutics, successfully โฆSee details»
Y-Biologics - Crunchbase Company Profile & Funding
Organization. Y-Biologics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number + โฆSee details»
Y-BIOLOGICS
Head Office: B715 Daedeok Biz Center, 17 Techno 4-ro, Yuseong-gu, Daejeon 34013 Korea Seoul Office: 601, LeadoneCenter, 91, Yangsan-ro, Yeongdeungpo-gu, Seoul 07261 Korea. โฆSee details»
YBiologics, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
100 Clinical Results associated with YBiologics, Inc. Login to view more data. 0 Patents (Medical) ... The statistics for drugs in the Pipeline is the current organization and its subsidiaries are โฆSee details»
Y Biologics | VentureRadar
Founded in 2007, Y-Biologics is a biotech company focusing on the discovery and development of novel antibody therapeutics based on its human... ... Find out more ...See details»
YBiologics Company Profile 2024: Stock Performance โฆ
YBiologics General Information Description. Y-Biologics Inc is a company that has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently โฆSee details»
Y-Biologics - LinkedIn
Y-Biologics is Koreaโs leading R&D biotech company in the field of antibody drug development. Since establishing Y-Biologics in 2007, our company has focused on the research and โฆSee details»
Y-Biologics Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Y-Biologics Inc. of Daejeon, Daejeon. Get the latest business insights from Dun & Bradstreet.See details»
Y-Biologics - Contacts, Employees, Board Members, Advisors
Y-Biologics is specialized in antibody drug since its inception has focused on research and developmentSee details»
Y-Biologics - Company Profile - Tracxn
Sep 29, 2024 Y-Biologics - Developer of antibodies for the treatment of multiple diseases. Raised a total funding of $9M over 1 round from 8 investors. Y-Biologics has 328 competitors.See details»
Y-Biologics - Overview, News & Similar companies - ZoomInfo
Jul 5, 2021 Y-Biologics contact info: Phone number: +82 428679971 Website: www.ybiologics.com What does Y-Biologics do? Founded in 2007, Y-Biologics is a biotech โฆSee details»
South-Korean biotech Y-Biologics and French mid-pharma Pierre โฆ
[email protected] . Pierre Fabre. Anne Kerveillant, Communication Manager +33 1 49 10 81 60 / +33 (0)6 20 88 54 57. [email protected] . We take care of life by โฆSee details»
(์ฃผ)์์ด๋ฐ์ด์ค๋ก์ง์ค
์์ด๋ฐ์ด์ค๋ก์ง์ค, ์๋ adc ์ฝํผ๋ฐ์ค์ ph-๊ฐ์ ํญ์ฒด ์ ๋ณด์ฌ. ํญ์ฒด ์ ์ฝ ๊ฐ๋ฐ ํ๋ซํผ ๊ธฐ์ ์์ด๋ฐ์ด์ค๋ก์ง์ค(338840)๋ ์ง๋ 4์ผ๋ถํฐ 7์ผ(ํ์ง์๊ฐ)๊น์ง ๋ฏธ๊ตญ ์๋์์ด๊ณ ์์ ๊ฐ์ต๋ '์๋ โฆSee details»
Y-Biologics: utilizing innate assembly mechanisms in cell lines to ...
Bispecific antibodies combine two therapeutic antibodies into one, simultaneously utilizing the effect of both to benefit patients. However, currently available technologies to produce these โฆSee details»
Y-BIOLOGICS
Signed a license agreement with Pyxis Oncology for YBL-001 jointly developed with LegoChem Biosciences press release. Signed a license agreement with 3D Medicines (3D MED) for the โฆSee details»
Y Biologics - VentureRadar
Website: http://ybiologics.com/ Develops novel antibody therapeutics using proprietary human antibody library Ymax®-ABL and bispecific antibody platform technology ...See details»
Y-Biologics and Pierre Fabre confirms their research collaboration โฆ
Daejeon (South Korea), Castres (France), March 29th, 2021 โ The South Korean biotech company Y-Biologics and the French pharmaceutical group Pierre Fabre announce the โฆSee details»
Y-BIOLOGICS
Exploring Antibodies, Creating Novel Therapeutics ํญ์ฒด์ ์ฝ ์ฐ๊ตฌ·๊ฐ๋ฐ ๋ถ์ผ ์ ๋ฌธ๊ธฐ์ ์ผ๋ก์ ๊ธ๋ก๋ฒ ํญ์ฒด์ ์ฝ ๋ฆฌ๋๊ฐ ๋๊ธฐ ์ํด โ์ฐ์ํ ํญ์ฒด๋ฐ๊ตดโ๊ณผ โํ๋ซํผ ๊ธฐ์ ํ๋ฆฝโ์ ์ง์คํ๊ณ ์์ต๋๋ค. โฆSee details»
Y-BIOLOGICS
Preclinical characterization of YBL-006, a fully human anti-PD-1 antibody being ready for clinical studies., CANCER RESEARCH, 2020. Interim analysis of first-in-human phase 1 study to โฆSee details»